SeaCrest Wealth Management’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-15,834
| Closed | -$297K | – | 563 |
|
|
2019
Q3 | $297K | Sell |
15,834
-3,529
| -18% | -$66.2K | 0.06% | 397 |
|
|
2019
Q2 | $409K | Buy |
19,363
+18,213
| +1,584% | +$385K | 0.08% | 291 |
|
|
2019
Q1 | $24K | Sell |
1,150
-250
| -18% | -$5.22K | ﹤0.01% | 1210 |
|
|
2018
Q4 | $26K | Hold |
1,400
| – | – | 0.01% | 1129 |
|
|
2018
Q3 | $35K | Hold |
1,400
| – | – | 0.01% | 1144 |
|
|
2018
Q2 | $34K | Hold |
1,400
| – | – | 0.01% | 1136 |
|
|
2018
Q1 | $41K | Hold |
1,400
| – | – | 0.01% | 1034 |
|
|
2017
Q4 | $33K | Buy |
+1,400
| New | +$33K | 0.01% | 1131 |
|